Cancer Hormone Therapy Drugs Market, Global Outlook and Forecast 2023-2028

Report ID: 1372444 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Cancer Hormone Therapy Drugs Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cancer Hormone Therapy Drugs Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cancer Hormone Therapy Drugs Overall Market Size
    2.1 Global Cancer Hormone Therapy Drugs Market Size: 2021 VS 2028
    2.2 Global Cancer Hormone Therapy Drugs Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Cancer Hormone Therapy Drugs Players in Global Market
    3.2 Top Global Cancer Hormone Therapy Drugs Companies Ranked by Revenue
    3.3 Global Cancer Hormone Therapy Drugs Revenue by Companies
    3.4 Top 3 and Top 5 Cancer Hormone Therapy Drugs Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Cancer Hormone Therapy Drugs Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Cancer Hormone Therapy Drugs Players in Global Market
        3.6.1 List of Global Tier 1 Cancer Hormone Therapy Drugs Companies
        3.6.2 List of Global Tier 2 and Tier 3 Cancer Hormone Therapy Drugs Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Cancer Hormone Therapy Drugs Market Size Markets, 2021 & 2028
        4.1.2 Tamoxifen
        4.1.3 Aromatase Inhibitors
        4.1.4 Antiandrogens
        4.1.5 Androgen Synthesis Inhibitors
        4.1.6 Other
    4.2 By Type - Global Cancer Hormone Therapy Drugs Revenue & Forecasts
        4.2.1 By Type - Global Cancer Hormone Therapy Drugs Revenue, 2017-2022
        4.2.2 By Type - Global Cancer Hormone Therapy Drugs Revenue, 2023-2028
        4.2.3 By Type - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Cancer Hormone Therapy Drugs Market Size, 2021 & 2028
        5.1.2 Breast Cancer
        5.1.3 Prostate Cancer
    5.2 By Application - Global Cancer Hormone Therapy Drugs Revenue & Forecasts
        5.2.1 By Application - Global Cancer Hormone Therapy Drugs Revenue, 2017-2022
        5.2.2 By Application - Global Cancer Hormone Therapy Drugs Revenue, 2023-2028
        5.2.3 By Application - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Cancer Hormone Therapy Drugs Market Size, 2021 & 2028
    6.2 By Region - Global Cancer Hormone Therapy Drugs Revenue & Forecasts
        6.2.1 By Region - Global Cancer Hormone Therapy Drugs Revenue, 2017-2022
        6.2.2 By Region - Global Cancer Hormone Therapy Drugs Revenue, 2023-2028
        6.2.3 By Region - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Cancer Hormone Therapy Drugs Revenue, 2017-2028
        6.3.2 US Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.3.3 Canada Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.3.4 Mexico Cancer Hormone Therapy Drugs Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Cancer Hormone Therapy Drugs Revenue, 2017-2028
        6.4.2 Germany Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.3 France Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.4 U.K. Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.5 Italy Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.6 Russia Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.7 Nordic Countries Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.4.8 Benelux Cancer Hormone Therapy Drugs Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Cancer Hormone Therapy Drugs Revenue, 2017-2028
        6.5.2 China Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.5.3 Japan Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.5.4 South Korea Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.5.5 Southeast Asia Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.5.6 India Cancer Hormone Therapy Drugs Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Cancer Hormone Therapy Drugs Revenue, 2017-2028
        6.6.2 Brazil Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.6.3 Argentina Cancer Hormone Therapy Drugs Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Cancer Hormone Therapy Drugs Revenue, 2017-2028
        6.7.2 Turkey Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.7.3 Israel Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.7.4 Saudi Arabia Cancer Hormone Therapy Drugs Market Size, 2017-2028
        6.7.5 UAE Cancer Hormone Therapy Drugs Market Size, 2017-2028
7 Players Profiles
    7.1 Roche
        7.1.1 Roche Corporate Summary
        7.1.2 Roche Business Overview
        7.1.3 Roche Cancer Hormone Therapy Drugs Major Product Offerings
        7.1.4 Roche Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.1.5 Roche Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Cancer Hormone Therapy Drugs Major Product Offerings
        7.2.4 Amgen Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 Pfizer
        7.3.1 Pfizer Corporate Summary
        7.3.2 Pfizer Business Overview
        7.3.3 Pfizer Cancer Hormone Therapy Drugs Major Product Offerings
        7.3.4 Pfizer Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.3.5 Pfizer Key News
    7.4 Teva
        7.4.1 Teva Corporate Summary
        7.4.2 Teva Business Overview
        7.4.3 Teva Cancer Hormone Therapy Drugs Major Product Offerings
        7.4.4 Teva Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.4.5 Teva Key News
    7.5 Takeda
        7.5.1 Takeda Corporate Summary
        7.5.2 Takeda Business Overview
        7.5.3 Takeda Cancer Hormone Therapy Drugs Major Product Offerings
        7.5.4 Takeda Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.5.5 Takeda Key News
    7.6 Samyang Biopharmaceuticals
        7.6.1 Samyang Biopharmaceuticals Corporate Summary
        7.6.2 Samyang Biopharmaceuticals Business Overview
        7.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Major Product Offerings
        7.6.4 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.6.5 Samyang Biopharmaceuticals Key News
    7.7 Tolmar
        7.7.1 Tolmar Corporate Summary
        7.7.2 Tolmar Business Overview
        7.7.3 Tolmar Cancer Hormone Therapy Drugs Major Product Offerings
        7.7.4 Tolmar Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.7.5 Tolmar Key News
    7.8 AstraZeneca
        7.8.1 AstraZeneca Corporate Summary
        7.8.2 AstraZeneca Business Overview
        7.8.3 AstraZeneca Cancer Hormone Therapy Drugs Major Product Offerings
        7.8.4 AstraZeneca Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.8.5 AstraZeneca Key News
    7.9 Novartis
        7.9.1 Novartis Corporate Summary
        7.9.2 Novartis Business Overview
        7.9.3 Novartis Cancer Hormone Therapy Drugs Major Product Offerings
        7.9.4 Novartis Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.9.5 Novartis Key News
    7.10 Aspen
        7.10.1 Aspen Corporate Summary
        7.10.2 Aspen Business Overview
        7.10.3 Aspen Cancer Hormone Therapy Drugs Major Product Offerings
        7.10.4 Aspen Cancer Hormone Therapy Drugs Revenue in Global Market (2017-2022)
        7.10.5 Aspen Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Cancer Hormone Therapy Drugs Market Opportunities & Trends in Global Market
    Table 2. Cancer Hormone Therapy Drugs Market Drivers in Global Market
    Table 3. Cancer Hormone Therapy Drugs Market Restraints in Global Market
    Table 4. Key Players of Cancer Hormone Therapy Drugs in Global Market
    Table 5. Top Cancer Hormone Therapy Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Cancer Hormone Therapy Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Cancer Hormone Therapy Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Cancer Hormone Therapy Drugs Product Type
    Table 9. List of Global Tier 1 Cancer Hormone Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cancer Hormone Therapy Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Cancer Hormone Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Cancer Hormone Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Cancer Hormone Therapy Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Cancer Hormone Therapy Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Cancer Hormone Therapy Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Cancer Hormone Therapy Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. Roche Corporate Summary
    Table 31. Roche Cancer Hormone Therapy Drugs Product Offerings
    Table 32. Roche Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Cancer Hormone Therapy Drugs Product Offerings
    Table 35. Amgen Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Pfizer Corporate Summary
    Table 37. Pfizer Cancer Hormone Therapy Drugs Product Offerings
    Table 38. Pfizer Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Teva Corporate Summary
    Table 40. Teva Cancer Hormone Therapy Drugs Product Offerings
    Table 41. Teva Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. Takeda Corporate Summary
    Table 43. Takeda Cancer Hormone Therapy Drugs Product Offerings
    Table 44. Takeda Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Samyang Biopharmaceuticals Corporate Summary
    Table 46. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product Offerings
    Table 47. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Tolmar Corporate Summary
    Table 49. Tolmar Cancer Hormone Therapy Drugs Product Offerings
    Table 50. Tolmar Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. AstraZeneca Corporate Summary
    Table 52. AstraZeneca Cancer Hormone Therapy Drugs Product Offerings
    Table 53. AstraZeneca Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Novartis Corporate Summary
    Table 55. Novartis Cancer Hormone Therapy Drugs Product Offerings
    Table 56. Novartis Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Aspen Corporate Summary
    Table 58. Aspen Cancer Hormone Therapy Drugs Product Offerings
    Table 59. Aspen Cancer Hormone Therapy Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Cancer Hormone Therapy Drugs Segment by Type in 2021
    Figure 2. Cancer Hormone Therapy Drugs Segment by Application in 2021
    Figure 3. Global Cancer Hormone Therapy Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cancer Hormone Therapy Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cancer Hormone Therapy Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2021
    Figure 8. By Type - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 12. US Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 24. China Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Cancer Hormone Therapy Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Cancer Hormone Therapy Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. Roche Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Pfizer Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Teva Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Takeda Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Tolmar Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. AstraZeneca Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Novartis Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Aspen Cancer Hormone Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Cancer Hormone Therapy Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Hormone Therapy Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Hormone Therapy Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports